Incyte (INCY) EBT Margin (2010 - 2026)

Incyte (INCY) reported EBT Margin of 27.0% for Q1 2026, up 476.0% on a YoY basis from 4.69% in Q1 2025, and up 4.33% quarter-over-quarter from 25.88% in Q4 2025.

Incyte (INCY) EBT Margin (2010 - 2026) Analysis & Trends

Incyte has reported EBT Margin for 17 years, with the latest figure at 27.0% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 476.0% year-over-year to 27.0%; the trailing twelve-month figure through Mar 2026 stood at 33.09% (up 2596.0% YoY), and the FY2025 full-year result was 32.37%, up 2491.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 27.0%, up from 25.88% in the prior quarter.
  • The five-year high for EBT Margin was 45.91% in Q2 2025, with the low at 37.34% in Q2 2024.
  • Historically, EBT Margin has averaged 19.73% across 5 years, with a median of 25.44% in 2023.
  • Annual changes were most pronounced in 2024 — EBT Margin tumbled 6642 bps — and 2025, when it soared 8325 bps.
  • Incyte's EBT Margin stood at 8.7% in 2022, then soared by 207 bps to 26.74% in 2023, then decreased by 0 bps to 26.62% in 2024, then dropped by 3 bps to 25.88% in 2025, then climbed by 4 bps to 27.0% in 2026.
  • The last three EBT Margin figures came in at 27.0% (Q1 2026), 25.88% (Q4 2025), and 35.31% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 27.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 27.00%
Dec 31, 2025 25.88%
Sep 30, 2025 35.31%
Jun 30, 2025 45.91%
Mar 31, 2025 22.24%
Dec 31, 2024 26.62%
Sep 30, 2024 13.76%
Jun 30, 2024 -37.34%
Mar 31, 2024 26.81%
Dec 31, 2023 26.74%
Sep 30, 2023 25.44%
Jun 30, 2023 29.08%
Mar 31, 2023 6.41%
Dec 31, 2022 8.70%
Sep 30, 2022 18.05%
Jun 30, 2022 25.17%
Mar 31, 2022 9.62%
Dec 31, 2021 13.91%
Sep 30, 2021 25.77%
Jun 30, 2021 24.32%